Post-ERCP Abdominal Pain in a Patient with Prior Sphincterotomy
A 58-year-old woman with a history of recurrent choledocholithiasis undergoes ERCP for suspected common bile duct stones. She has had a prior sphincterotomy 2 years ago. The procedure is performed under moderate sedation with midazolam and fentanyl. Cannulation is achieved, and a balloon sweep extracts a 6 mm stone. The endoscopist notes mild oozing from the papilla, which stops spontaneously. The total procedure time is 35 minutes. Two hours post-procedure, the patient develops severe epigastric pain radiating to the back, nausea, and vomiting. Vital signs: HR 110, BP 130/80, RR 22, Temp 37.8°C. Physical exam reveals epigastric tenderness without rebound or guarding. Serum lipase is 450 U/L (normal <60). CBC shows WBC 14,000/µL. Liver enzymes are mildly elevated (ALT 80 U/L, AST 70 U/L).
1. What is the most likely diagnosis, and what risk factors in this patient's history and procedure increase the likelihood of this complication?
Read the worked answer
The most likely diagnosis is post-ERCP pancreatitis (PEP). The patient meets the criteria: new or worsened abdominal pain, elevated lipase >3x upper limit of normal, and hospitalization >2 nights (or >24 hours). Risk factors include: prior sphincterotomy (paradoxically, prior sphincterotomy is associated with a lower risk of PEP, but the patient had a procedure that involved manipulation of the papilla), difficult cannulation (not explicitly stated but implied by the need for balloon sweep), balloon sphincteroplasty (if performed), moderate sedation (not a risk factor), female sex, prior recurrent choledocholithiasis (not a direct risk factor), and procedure time >30 minutes (35 min is borderline). However, the most significant risk factors here are female sex and prior sphincterotomy (which actually reduces risk). Wait-re-evaluate: The patient has a prior sphincterotomy, which is a protective factor for PEP. But she still developed it. Other risk factors: age <60, female, prior PEP, sphincter of Oddi dysfunction (not present), difficult cannulation (not specified), pancreatic injection (not specified), balloon dilation (not specified). The key is that the diagnosis is PEP based on clinical and lab findings. The risk factors present: female sex, age <60, and possibly difficult cannulation. The prior sphincterotomy is protective. So the answer should highlight that despite protective factors, PEP can occur. The most likely diagnosis is PEP. Risk factors: female sex, age <60, and the procedure itself (ERCP). Also, the use of moderate sedation may mask early symptoms but not a risk factor. The oozing from papilla is not a risk factor. So the answer: PEP, with risk factors female sex, age <60, and ERCP procedure. Prior sphincterotomy is protective. The patient's lipase >3x ULN and pain confirm diagnosis.
2. Outline the immediate management steps for this patient, including pharmacological interventions and disposition. What would you recommend for prophylaxis in future ERCPs?
Read the worked answer
Immediate management: NPO, IV fluids (aggressive hydration with lactated Ringer's solution at 3 mL/kg/hr), analgesia (opioids), antiemetics. Monitor vitals and urine output. Check CBC, BMP, and lipase again in 12-24 hours. Disposition: admit for observation and hydration. If severe, consider ICU. Prophylaxis for future ERCPs: rectal indomethacin (100 mg) or diclofenac immediately before or after the procedure, pancreatic stent placement if high risk, and hydration with lactated Ringer's. Since she had a prior sphincterotomy, the risk is lower, but still consider rectal NSAIDs. Also, avoid unnecessary cannulation of the pancreatic duct. The patient should be counseled on signs of PEP.